Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan

被引:44
作者
Chou, Chen-Kai [1 ]
Weng, Shao-Wen [1 ]
Chang, Hsueh-Wen [2 ]
Chen, Chih-Yin [1 ]
Su, Sheng-Chi [1 ]
Liu, Rue-Tsuan [1 ]
机构
[1] Chang Gung Med Coll, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Internal Med,Div Metab, Kaohsiung, Taiwan
[2] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan
关键词
peripheral arterial disease; ankle-brachial index; chronic kidney disease;
D O I
10.1016/j.diabres.2008.04.027
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims: Diagnosing peripheral arterial disease (PAD) and recognizing its associated risk factors in diabetes is important due to high cardiovascular disease and limb loss risk. However, both traditional and nontraditional risk factors have seldom been analyzed in the same diabetic cohort. The aim of this study was to examine the traditional and nontraditional risk factors for PAD in elderly type 2 diabetic patients. Methods: Five hundred and eighty type 2 diabetic subjects aged >= 60 years were cross-sectionally studied. Diagnosis of PAD was by ankle-brachial index (ABI) <0.90 on either leg. The association between traditional and nontraditional risk factors of PAD was analyzed. Results: Among the confounders, age, diabetes duration, HDL cholesterol, albuminuria, CKD (chronic kidney disease), hsCRP and insulin use differed between patients with and without PAD. Multiple logistic regression revealed that only CKD, insulin use, albuminuria, elevated hsCRP level (>3 mg/l) and low HDL cholesterol were independent risk factors. Conclusions: The findings of this study highlight the importance of monitoring nontraditional risk factors of PAD in diabetes. Implementing effective interventions to improve management of these risk factors may lower the risk for PAD. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 39 条
[1]
UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes [J].
Adler, AI ;
Stevens, RJ ;
Neil, A ;
Stratton, IM ;
Boulton, AJM ;
Holman, RR .
DIABETES CARE, 2002, 25 (05) :894-899
[2]
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]
2-S
[4]
Renal damage in patients with Type 2 diabetes: a strong predictor of mortality [J].
Bo, S ;
Ciccone, G ;
Rosato, R ;
Gancia, R ;
Grassi, G ;
Merletti, F ;
Pagano, GF .
DIABETIC MEDICINE, 2005, 22 (03) :258-265
[5]
Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study [J].
Chien, KL ;
Hsu, HC ;
Sung, FC ;
Su, TC ;
Chen, MF ;
Lee, YT .
ATHEROSCLEROSIS, 2005, 183 (01) :147-155
[6]
Clark N, 2003, DIABETES CARE, V26, P3333
[7]
Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[8]
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, ME ;
Mitch, WE ;
Brenner, BM .
CIRCULATION, 2004, 110 (08) :921-927
[9]
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, MF ;
Mitch, WE ;
Brenner, BM .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320
[10]
C-reactive protein in ischemic stroke - An independent prognostic factor [J].
Di Napoli, M ;
Papa, F ;
Bocola, V .
STROKE, 2001, 32 (04) :917-924